Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia

BACKGROUND: Better treatments for schizophrenia are urgently needed. The therapeutic use of the nitric oxide (NO)-donor sodium nitroprusside (SNP) in patients with schizophrenia has shown promising results. The role of NO in schizophrenia is still unclear, and NO modulation is unexplored in ketamine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Neurosci
Main Authors: Kandratavicius, Ludmyla, Balista, Priscila Alves, Wolf, Daniele Cristina, Abrao, Joao, Evora, Paulo Roberto, Rodrigues, Alfredo Jose, Chaves, Cristiano, Maia-de-Oliveira, Joao Paulo, Leite, Joao Pereira, Dursun, Serdar Murat, Baker, Glen Bryan, Guimaraes, Francisco Silveira, Hallak, Jaime Eduardo Cecilio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354998/
https://ncbi.nlm.nih.gov/pubmed/25887360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12868-015-0149-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados